36
Participants
Start Date
March 31, 2012
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
mPEG-r-crisantaspase
IV infusion over 60 minutes of mPEG-r-crisantaspase given once every two or four weeks for two administrations. Based on non-clinical data, 500IU/m2 has been selected as the starting dose. Dose selection will proceed based upon safety and pharmacokinetic data but escalation will not exceed 100%
Institut Claudius Regaud, Toulouse
Hospices Civils de Lyon, Pierre-Bénite
Centre Henri Becquerel, Rouen
Hôpital Henri Mondor, Créteil
Hôpitaux du CHU de Nantes, Nantes
Lead Sponsor
EUSA SAS
UNKNOWN
The Lymphoma Academic Research Organisation
OTHER
Jazz Pharmaceuticals
INDUSTRY